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Introduction
Hypertension is a major public health issue in the United States. According to the National
Health and Nutrition Examination Survey for the year of 2011–2012, 29.1% of the adult
population in the United States has been diagnosed with hypertension and 76% of individuals
with hypertension are treated with blood pressure medications (Centers for Disease Control and
Prevention, 2013). In 2010, the direct spending to treat hypertension in the United States was
$42.9 billion, and of that total, $20.4 billion was spent on antihypertensive medications (Davis,
2013). Unfortunately, the trend is only expected to increase as the current population continues
to age.
Hypertension represents a population health issue in that many patients are misdiagnosed and
over-or-under medicated. Research has indicated that overestimating the true blood pressure by 5
mmHg leads to over 30 million Americans being inappropriately treated with blood pressure
medication (Handler, 2009). Underestimates of true blood pressure by 5 mmHg may lead to an
incorrect diagnosis of pre-hypertension, when the patient is in fact hypertensive (Handler, 2009).
Although 24-hour ambulatory and home blood pressure monitoring are more reliable methods of
measuring hypertension, office blood pressure measurement remains the standard protocol to
diagnose and manage this chronic disease (Centers for Disease Control and Prevention, 2013).
Blood pressure measurements taken in the office are often inaccurate due to patient behaviors,
improper technique, and observer errors, yet providers are still using this method to diagnose
hypertension. Therefore, considering other methods of blood pressure for the diagnosis and
management of hypertension is important to the healthcare quality for millions of Americans.
The main objective of this capstone research is to identify, categorize, and assess the barriers
and facilitators to ambulatory, office, and home blood pressure monitoring, using both an
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evidence-based review of literature and the qualitative perspective of key informants from
primary care practices around Maine. This research was examined within the context of the
Triple Aim categories of population health, experience of care, and per capita cost (Institute for
Healthcare Improvement, 2014). The goal is to provide primary care practices with the necessary
background to make informed decisions about when and why these various blood pressure
monitoring methods should be used in order to improve the patient experience and population
health, and reduce healthcare costs.
Methods
Literature Review
A literature review was conducted to discover the benefits, drawbacks, barriers, and
facilitators of the three primary blood pressure monitoring methods, both from a clinical and
qualitative perspective. These methods were compared in terms of clinical outcomes, variability
and number of readings, measurement error, white coat hypertension, diagnostic accuracy, cost,
and patient experience. Numerous studies were reviewed to compare these aspects of the
different methods of blood pressure monitoring. Additionally, a secondary review of
hypertension diagnosis and management studies focused on the barriers and facilitators to the
Triple Aim was initiated in order to support findings from the key informant interviews.
The evidence-based and peer-reviewed literature search was conducted using the following
databases: CINAHL, Health Source: Nursing/Academic Edition, MEDLINE, Nursing and Allied
Health Collection, and Google Scholar. The key words used in the searches were hypertension,
white coat hypertension, blood pressure measurement, hypertension management, ambulatory
blood pressure measurement, office blood pressure measurement, and home blood pressure
measurement.
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Key Informant Interviews
Key informant interviews were conducted with healthcare professionals from primary care
practices in Maine. Inclusion criteria required that the participant have a significant amount of
knowledge about the various blood pressure monitoring methods available, the protocols for
diagnosing and managing hypertension within their practice, as well as a basic understanding of
the Triple Aim framework; population health, experience of care, and per capita cost. The key
informants were practice managers, medical directors, or clinical quality coordinators in primary
care practices. All of the study participants had a great deal of expertise in the area of quality
improvement and clinical processes, as well as any population health initiatives being
implemented within their practice focusing on hypertension management.
Informed consent was obtained from all study participants. The recruitment letter, consent
form, and interview questions were approved by the University of Southern Maine’s Institutional
Review Board before any portion of the key informant interviews were conducted. The data
collected from each interview was analyzed and compared qualitatively to the other practices
interviewed, and then cross analyzed with the current research available with respect to the
Triple Aim. Five primary care practices were selected in advance and three practices agreed to
participate in the interview process. (The general recruitment letter and interview questions are
included in the Appendices).
Definitions
The following terms are defined to ensure consistency in data interpretation:
Hypertension is diagnosed when two or more readings are greater than or equal to 140/90
mmHg on two or more occasions taken by a health care provider in the office. When using 24hour ambulatory blood pressure monitors, a hypertension diagnosis is made when the average
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blood pressure is greater than 135/85 mmHg (U.S. Department of Health and Human Services,
2004).
White coat hypertension is a phenomenon in which patients present with a much higher blood
pressure reading in the office as compared to the home and ambulatory blood pressure
measurement methods. This is thought to be due to the anxiety that they experience when
encountering a health care professional (Pickering, Gerin, & Schwartz, 2002). For example, an
individual with white coat hypertension may have daytime blood pressure values less than
135/85 mmHg, but office values greater than or equal to 140/90 mmHg (Veglio, et al., 2001).
Office blood pressure measurement/monitoring (OBPM) is conducted in the clinic setting by
an experienced health care professional. For the purposes of this particular study, manual
equipment is used to record blood pressures in the medical office setting.
Home blood pressure measurement/monitoring (HBPM) is performed by the patient or
assisted by another individual in the comfort of their home, usually on a daily basis. The
equipment is automated and user-friendly.
24-hour ambulatory blood pressure measurement/monitoring (ABPM) is a method in which
the patient is fitted with blood pressure equipment and wears it continuously for 24 hours.
Readings are taken automatically throughout the day and night, generally every 15 minutes. The
daytime readings are then averaged together to obtain an average blood pressure reading. This
method requires an initial office visit and follow-up office visit in 24 hours (U.S. Department of
Health and Human Services, 2004). Ambulatory blood pressure measurement is considered the
“gold standard” in terms of accuracy of blood pressure measurement (Kaczorowski, Dawes, &
Gelfer, 2012).
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Results
Literature Finding
Clinical Outcomes
Ambulatory blood pressure monitoring is considered to have “demonstrated superiority over
office blood pressure in terms of…relation to the impact on target organs and ability to predict
cardiovascular events” (Gosse & Coulon, 2009, p. 234). Several researchers (Kaczorowski,
Dawes, & Gelfer, 2012; Lovibond, et al., 2011; Rodriguez-Roca, et al., 2006; Vilaplana, 2006;
Vollmer, et al., 2005) have also presented evidence that ambulatory blood pressure monitoring is
more accurate at identifying target organ damage and predicting cardiovascular events than
office blood pressure monitoring. Kaczorowski, Dawes, and Gelfer (2012) stated that the
“combination of many accurate readings results in a better predictor of mortality and morbidity
associated with hypertension” (p. 401). This prediction aspect of ABPM can improve the health
of the hypertensive patient population by providing further data on the many morbidities
associated with hypertension. ABPM has the ability to predict cardiovascular events because it
records the percentage of elevated blood pressure readings, as well as the how much the blood
pressure decreases during sleep. A patient is at significant risk for a cardiovascular event should
the blood pressure not decrease during the sleep cycle (Vilaplana, 2006).
Improved clinical outcomes for hypertensive patients are also observed with regular home
blood pressure monitoring if patients use a validated home blood pressure machine correctly.
“Home monitoring also correlates better with target organ damage and cardiovascular mortality
than office measurement, enables the prediction of sustained hypertension in patients with
borderline hypertension and...can better assess drug efficacy” (Kaczorowski, Dawes, & Gelfer,
2012, p. 402). Vilaplana (2006) supports this conclusion and also adds that home blood pressure
can be more reproducible than office values and may also provide information on a patient’s
response to antihypertensive medications.
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Unfortunately, the most commonly used form of blood pressure monitoring, OBPM, is not a
predictor of cardiovascular events and cannot identify target organ damage. The evidence-based
and peer-reviewed literature indicate that due to its inability to improve health outcomes
compared to ABPM and HBPM, it is not a facilitator for the population health aspect of the
Triple Aim.
Variability and Number of Readings
Both ambulatory and home blood pressure monitoring can capture multiple measurements
and reduce the variability of the readings (Gosse & Coulon, 2009; Vollmer, et al., 2005). The
added benefit of home blood pressure monitoring’s ability to obtain multiple readings is that it
“provides us with values from different days, in settings as close to daily life as possible”
(Vilaplana, 2006, p. 212). This feature also makes home blood pressure monitoring superior to
ambulatory blood pressure monitoring because ambulatory blood pressure monitoring is done
over the course of 24 hours, where as home monitoring can occur multiple times a day and is
also done daily over a long period of time. However, ambulatory blood pressure monitoring is
still more effective than office blood pressure monitoring due to its ability to take multiple
readings over 24 hours and is sometimes used as a supplemental diagnostic tool, especially due
to variability concerns with the office measurement. OBPM generally consists of a single
measurement at an office visit, nurse visit, or physical exam and can vary greatly from visit to
visit.
Measurement Error
The main issues surrounding blood pressure measurement error are improper technique,
inadequate training, and observer bias. Ambulatory and home blood pressure monitoring
eliminate observer bias due to the automation of the equipment (Gosse & Coulon, 2009)
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(Vollmer, et al., 2005). However, it is important to note that clinicians do need to be trained to
properly apply ambulatory blood pressure monitoring equipment on the patient. There can be
measurement error with home blood pressure monitoring, as well. Patients may not follow the
proper techniques to obtain an accurate blood pressure reading or the equipment may not be
validated, and can therefore become an unreliable source of blood pressure readings (Gosse &
Coulon, 2009).
Office blood pressure monitoring is much more vulnerable to measurement error than the
other two methods. Kaczorowski, Dawes, and Gelfer (2012) found that “there is growing
evidence that because of poor measurement techniques that include the use of uncalibrated
sphygmomanometers, inappropriate cuff size, zero-digit bias, patient clinician interaction during
measurement, and failure to reduce patient anxiety, the blood pressure readings obtained in
routine clinical practice are often imprecise and inconsistent (p. 400)”. These issues are also cited
in online training program developed by MCD Public Health (2014). Gosse and Coulon (2009)
found that office blood pressure readings often result in a false positive diagnosis of
hypertension, especially when the measurement is near the cutoff point for normal blood
pressure. Additionally, improper measurement techniques can lead to both over- and
underestimation of blood pressure values (Kaczorowski, Dawes, & Gelfer, 2012). Measurement
error is costly in terms of prescribing unnecessary antihypertensive medications and population
health.
White Coat Hypertension
White coat hypertension occurs mainly in the office or clinical setting. It stems from the
anxiety patients have when they are around health care professionals in white coats. “Frequently,
the patient is [white coat hypertensive] and may demonstrate office hypertension; office blood
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pressure is often higher than home and ambulatory blood pressure” (Veglio, et al., 2001, p. 208).
Therefore, office blood pressure measurement and monitoring is subject to white coat
hypertension (Gosse & Coulon, 2009). In the study performed by Rodriguez-Roca, et al., (2006)
the researchers found that 20% of hypertensive patients that are diagnosed using office blood
pressure readings are false-positives, mainly due to white coat hypertension. Oftentimes, patients
are prescribed blood pressure lowering medications when they are, in fact, white coat
hypertensive and do not need medication (Ogedegbe, et al., 2008). The treatment of white coat
hypertension is very wasteful of limited healthcare resources, costly, and can result in negative
side effects for the patient (Zawadzka, Bird, Casadei, & Conway, 1998).
Ambulatory blood pressure monitoring is considered to be superior in identifying white coat
hypertension compared to home blood pressure monitoring and office blood pressure monitoring
(Carney, Gillies, Garvey, & Smith, 2005). However, home blood pressure monitoring still has
the ability to identify and evaluate white coat hypertension (Gosse & Coulon, 2009) (Vilaplana,
2006). In the study performed by Zawadzka, Bird, Casadei, and Conway (1998), they sampled
410 patients that had been diagnosed with hypertension, but were not on any antihypertensive
medications and used ambulatory blood pressure monitoring to confirm the hypertension
diagnosis. Out of 410 subjects, 124 of the participants actually had white coat hypertension, over
30% of the patient population had been incorrectly diagnosed with hypertension due to the
inability of office blood pressure monitoring to identify white coat hypertension.
Diagnostic Accuracy
Ambulatory blood pressure monitoring is far more accurate in identifying hypertension
compared to office and home blood pressure monitoring. “This means that fewer people who are
not hypertensive will be incorrectly diagnosed as positive. This results in fewer people being
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offered antihypertensive medications” (National Institute for Health and Clinical Excellence,
2011, p. 13). Due to its accuracy, it also identifies more true hypertensive patients than office
blood pressure monitoring and can therefore aid in improving population health and the patient
experience by ensuring that people will receive the treatment they need. ABPM has a high
specificity and enhanced precision compared to the other two methods and has been noted in
several studies to improve health outcomes and reduce the need of antihypertensive medications
due to its accurate measurements (Lovibond, et al., 2011; Rodriguez-Roca, et al., 2006; Vollmer,
et al., 2005). In the Lovibond, et al. (2011) study, part of their research indicated that ambulatory
blood pressure monitoring improved health outcomes in male and female hypertensive patients
over the age of 50 due to an increase in quality-adjusted life years (QALY) compared to office
and home blood pressure monitoring. However, home blood pressure monitoring is still much
more accurate in diagnosing hypertension compared to office blood pressure monitoring
(Kaczorowski, Dawes, & Gelfer, 2012).
Cost
Diagnostic accuracy and identifying white coat hypertension are key contributors to cost.
There are contradictory findings about which blood pressure monitoring methods cost more.
Gosse and Coulon (2009) cited cost as a barrier to the availability of ambulatory blood pressure
monitoring and found that many health insurances do not cover the use of ABPM. Vilaplana
(2006) also stated that the cost of ABPM equipment is a barrier to accessibility. However, three
cost-effective analysis studies found that ABPM is the most cost-effective strategy in the
diagnosis and management of hypertension. The National Institute for Health and Clinical
Excellence (NICE) (2011) found that although ambulatory blood pressure monitoring is more
costly than home and office blood pressure monitoring initially due to the high cost of the device
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and staff training, there are many cost savings through a decreased expenditure on
antihypertensive medications and annual monitoring appointments with primary care physicians.
NICE conducted a cost report to identify the savings incurred from using ABPM as a
supplementary diagnostic tool. The following table shows the savings for the National Health
Service in the United Kingdom:

Table 1: Cost savings with implementation of ABPM as a secondary diagnostic tool
Year
Change in
Change in
Net Resource
Diagnosis Cost
Treatment Cost
Impact
1
$8,550,000.00
-$4,170,000.00
$4,380,000.00
2
$8,550,000.00
-$9,679,000.00
-$1,129,000.00
3
$8,550,000.00
-$15,188,000.00
-$6,638,000.00
4
$8,550,000.00
-$20,696,000.00
-$12,146,000.00
5
$8,550,000.00
-$26,206,000.00
-$17,656,000.00
*Adapted from: (NICE, 2011, p. 17)

The values have been adapted from Euros to U.S. dollars. In the first year additional costs
associated with the implementation of ABPM will incur, but years four and five show a
significant savings from ABPM due to savings in medication costs and reduced office visits. The
savings may vary based on the fundamental differences of our healthcare system compared to the
United Kingdom, but savings are still expected with the increase in ABPM utilization.
The cost-effective analysis conducted by Kaczorowski, Dawes, and Gelfer (2012) revealed
that ambulatory monitoring is a more cost effective strategy compared to home and office blood
pressure monitoring. “The savings with ambulatory monitoring compared with monitoring in the
clinic and home were primarily because of the costs of hypertensive treatment that were avoided
because of the higher specificity of ambulatory monitoring” (Lovibond, et al., 2011, p. 1224).
This study assessed cost effectiveness by calculating costs, QALY, and incremental costs per
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QALY, and analyzed cost of antihypertensive treatment, cost of diagnosis, and the costs of the
management of cardiovascular disease.
Their analysis revealed reduced treatment costs for men over 60 years of age when
ambulatory or home blood pressure monitoring was implemented. Treatment costs for office
blood pressure monitoring were calculated to be $1306, home blood pressure monitoring cost
$1252, while ambulatory only cost $1062 per patient (Lovibond, et al., 2011). Lastly, in the
study performed by Rodriguez-Roca, et al. (2006), it was found that ABPM fostered a reduction
in direct costs associated with hypertension compared to OBPM and the initial and additional
costs of ABPM would be paid off after the first year of implementation.
Home blood pressure monitoring is also considered to be a less expensive option for
hypertension management compared to office blood pressure monitoring. Home blood pressure
monitoring leads to a reduction in office visits and a “29% mean adjusted cost reduction when
compared to usual care” (Carney, Gillies, Garvey, & Smith, 2005, p. 154). However, the use of
home blood pressure equipment requires clinicians to train patients how to properly use the
machine and this can be very time consuming and costly to a health care organization (Gosse &
Coulon, 2009). A research study comparing office blood pressure and home-blood pressure
monitoring found that those using home-blood pressure monitors used less medication and this
resulted in difference of $1000 per month between the two groups (Verberk, et al., 2007). Other
sources have cited the cost-effectiveness of home blood pressure monitoring compared to office
blood pressure monitoring because of fewer office visits and a decrease in antihypertensive
medications, but none of the studies identified HBPM as being more cost effective than ABPM
(Lovibond, et al., 2011; Vilaplana, 2006).
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Office blood pressure monitoring is considered the most costly method of managing
hypertension for several reasons; higher treatment costs, increased prescription of
antihypertensive medications, and more office visits (Lovibond, et al., 2011). Additionally,
“obtaining high quality office-based measurements requires extensive staff training and ongoing
quality control monitoring” (Vollmer, et al., 2005, p. 81). Many health care organizations are
implementing training programs for their staff to ensure that their clinicians know how to take a
proper blood pressure measurement. The cost of developing these training programs is high, but
it is also necessary and all blood pressure measurement methods require training of some sort.
Patient Experience
One of the most beneficial aspects of ambulatory and home blood pressure monitoring is that
the individual is able to be in their own environment when the blood pressure readings are taken,
which is a far more comfortable atmosphere for the patient and produces more accurate results
compared to office blood pressure monitoring (Gosse & Coulon, 2009; Rodriguez-Roca, et al.,
2006). However, a study conducted by Vollmer, et al. (2005) included a survey for patients to
assess whether the ambulatory blood pressure monitoring equipment interfered with their
activities of daily living (ADLs) and found that 45% of the patients surveyed felt that wearing
the monitor somewhat interfered with their ADLs and 5-10% of patients felt that wearing the
monitor interfered with their ADLs significantly. Another study revealed that many patients
disliked the ambulatory blood pressure equipment because the inflation of the cuff was relatively
uncomfortable (Rodriguez-Roca, et al., 2006). The interference and discomfort of the ABPM
equipment seems to be a barrier to improving the patient experience.
The findings regarding home blood pressure monitoring indicated that patients adhered to
their treatment regimen and were more participative in managing their hypertension (Carney,
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Gillies, Garvey, & Smith, 2005; Vilaplana, 2006). However, there is a concern that patients will
not document their measurements correctly or may change their medications before checking
with their physician (Vilaplana, 2006).
Key Informant Interview Findings
Study participants were recruited from primary care practices around Maine. Three key
informants chose to participate in the interview process and met the inclusion criteria for the
capstone research. The aim of the key informant interviews was to identify barriers and
facilitators to each of the components of the Triple Aim, provide information about their most
commonly used blood pressure monitoring method, and identify any current or future protocols
in the diagnosis and management of hypertension within their practice.
Interviewees One and Two revealed that their electronic health records are not designed to
provide patient population health data such as the percentage of hypertensive patients within a
practice. However, the second interviewee was able to provide an estimate of 27% of their
patient population having a diagnosis of hypertension, well in line with the national percentages.
The third interviewee was also able to provide an approximation of 28% of the patient
population having a diagnosis of hypertension within their organization, and did not note any
limitations of their electronic health records to capture population health data. All key informant
interviewees stated that all hypertension diagnoses are made with manual blood pressure
equipment and diagnoses are determined using the 8th Report of the Joint National Committee on
Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and that manual office
blood pressure method was the only method acceptable by the Joint National Committee for the
diagnosis of hypertension. Interviewee One and Two do not currently have a protocol in place
for the management of hypertension, but Interviewee Three indicated that there is a standard
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clinical training protocol in place within their organization, although some staff have yet to
receive the training. Interviewee One stated that there are pilot studies in place to design a
protocol and Interviewee Two stated that it is up to the primary care physicians to design a
management plan, and generally, when there is a medication change, the provider will request
that the patient comes back in one to two weeks and then monthly until the patient is wellcontrolled. Again, all organizations encourage and recommend home blood pressure monitoring
for hypertension management, but cite that there are barriers to this method such as cost to the
patient, errors associated with patient application and positioning of the cuff, willingness of the
patient to become engaged in this method, and that the blood pressure equipment may not be
validated.
Organization One differed from Organization Two and Three in that they use the ABPM for
patients that are suspected of having white coat hypertension, or are on multiple antihypertensive
medications but are still not controlled. Organization Two does not have any ambulatory blood
pressure monitoring equipment available to them at this time and Organization Three will
consult with a cardiologist and possibly refer a patient to have the ABPM conducted.
Organizations One and Three stated that the barriers to office blood pressure monitoring are
the availability of exam rooms and the cost to the patient; blood pressure checks require a
copayment for the insured or the entire cost of a nurse visit for those that are uninsured. Barriers
to ambulatory blood pressure monitoring are synonymous to the findings from the literature
review; insurance may not cover the cost of ABPM and the machine and cuff interfere with a
patient’s normal routine and is difficult to wear for 24 hours. Organization Two cited
transportation issues as a major barrier to OBPM, but the cost to the patient is a facilitator
because there is no charge for blood pressure checks and they offer prescription assistance to
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those who cannot afford medication. A barrier to HBPM is the cost of the equipment; they have
found that many people cannot afford a validated HBPM machine.
Interviewee Three offered a comprehensive list of barriers that included the fact that
electronic health records cannot currently integrate home blood pressure monitoring values into a
patient’s chart, the amount of time and skill of the staff to calibrate home blood pressure
monitors, and the cost differential between the three methods which encompass training, staff
preferences, and the cost of calibration and maintenance of the blood pressure equipment within
the practice. All interviewees noted that the continued use of office blood pressure monitoring
compared to other methods is due to the provider’s viewpoint that they have always used office
measurements to diagnose and manage hypertension and do not see a reason to change or
integrate another method.
The matrices on the following pages help to summarize the information gathered from the
research. Matrix one covers advantages and disadvantages of each method from a clinical
perspective and matrix two summarizes key barriers and facilitators to each method of blood
pressure measurement in terms of cost, patient experience, and population health.
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Matrix One: A clinical perspective of advantages and disadvantages of ABPM, HBPM, and OBPM.
ABPM
Predicts cardiovascular (CV) events,
identifies target organ damage, better
predictor of mortality and morbidity
associated with hypertension

HBPM
Improves clinical outcomes as well as
ABPM, enables prediction of
sustained hypertension, and can
predict CV events and identify target
organ damage

OBPM
Does not really predict CV events and
cannot identify target organ damage

Multiple
Measurements/
Variability

Multiple measurements can be taken,
variability of readings can be reduced,
only provides values for 24 hours, used
as a supplemental diagnostic tool when
there are variability concerns with
OBPM

Multiple measurements can be taken,
variability of readings can be reduced,
provides values from different days
over a long period of time

Normally consists of one
measurement at an office visit and can
vary greatly from visit to visit

Measurement
Error

Eliminate observer bias, requires staff
training

Eliminate observer bias, requires
patient training, patients may not
follow proper techniques, equipment
may not be validated

White Coat
Hypertension

Eliminates white coat hypertension and
identifies white coat hypertension better
than HBPM and OBPM

Eliminates white coat hypertension

Subject to observer bias, requires
extensive staff training and quality
control monitoring. Poor measurement
techniques: uncalibrated equipment,
wrong cuff size, talking during
measurement, zero-digit bias, failure
to reduce patient anxiety. Leads to
over and underestimation of blood
pressure values
20-30% of patients diagnosed with
hypertension by OBPM are white coat
hypertensive

Diagnostic
Accuracy

Most accurate in identifying
hypertension. High specificity and
enhanced precision, reduces need of
antihypertensive medications

2nd most accurate in identifying
hypertension, reduces need of
antihypertensive medications

Clinical
Outcomes

Least accurate due to improper
technique and observer bias
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Matrix Two: Barriers and facilitators to ABPM, HBPM, and OBPM in the context of the Triple Aim.

Cost

Patient
Experience

ABPM
Contradictory evidence. Initial
expense of equipment to practiceBarrier (B). Insurance may not
cover cost (B). Results in lack of
availability to patient and provider
(B). Considered most costeffective strategy due to reducing
need for medications and reduction
in office visits- Facilitator (F).
Reduced treatment costs.
Patient is in a familiar, comfortable
environment (F). Accurate results
lead to correct hypertension
diagnosis and proper medication, if
necessary (F). Interferes with daily
routine (B). Uncomfortable to wear
(B). Limited availability to patients
(B).

Prediction of CV events can
improve pop. health. Accuracy of
equipment will ensure patients
Population Health receive the correct treatment (F).
Inability of EHR's to quickly
identify percentage of patient
population that is hypertensive (B).

HBPM
Costly for some patients (B). However,
there is a 29% mean adjusted cost
reduction when compared to usual care
(F).

OBPM
Most costly to patients due to higher
treatment costs, increased prescribing
of antihypertensive medications, and
more office visits (B). Can be costly to
practices because of quality control
monitoring and extensive staff training
(B). Can be less costly when there is
no charge for a blood pressure check
(F).

Patient is in a familiar, comfortable
environment (F). Accurate results lead
to correct hypertension diagnosis and
proper medication, if necessary (F).
Increased adherence to treatment
regimen (F). Increased participation in
management of hypertension (F).
Patients may not have validated
equipment (B). Patients may change
medication dosage before checking
with their physician (B). Patients may
incorrectly place blood pressure cuff
(B). Patients may not want to engage in
HBPM (B).
Prediction of CV events can improve
pop. health. Accuracy of equipment
will ensure patients receive the correct
treatment (F). Inability of EHR's to
quickly identify percentage of patient
population that is hypertensive (B).

Patients can find it difficult to find
transportation to appointments (B).
Inaccurate measurements lead to over
or underestimating blood pressurepatients may be over or under treated
(B). Widely available to all patients
and providers (F). Most common way
of diagnosing hypertension (F).

Inability to predict CV events (B).
Inaccurate readings are common and
lead to over or under medicating (B).
Fastest, most convenient way to
identify normotensive patients (F).
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Limitations
Limitations of this research study can be partly attributed to recruiting challenges regarding
the key informant interviews. It is possible that organizations did not participate due to
transitions caused by the major reform of health systems. Many primary care practices are
working on accreditations and certifications to remain on par with other organizations. Many
upper-level staff are occupied with ensuring the appropriate requirements are fulfilled; this
leaves little time to focus on outside requests for interviews. Another issue pertaining to the
interviews was the small number of primary care practices that were selected to participate; this
author made an assumption that all recruited organizations would agree to an interview.
Additionally, due to the stipulations provided through the Institutional Review Board, potential
subject organizations had to be selected in advance. For future research, the selection of possible
practices should be much larger, allowing for negative responses while still managing to gather
sufficient and reliable qualitative data.
Additional limitations include the difficulty of evaluating qualitative data, as well as the lack
of sources comparing all three methods of blood pressure monitoring. Many of the studies
compared ambulatory or home blood pressure monitoring to office blood pressure monitoring,
making it difficult to accurately assess some aspects of the literature findings.
Discussion
The results of the literature indicate that ambulatory blood pressure monitoring is the most
accurate blood pressure method due to its specificity and ability to eliminate both observer bias
and the white coat effect. Home blood pressure monitoring is also an accurate method, but can be
inaccurate if the patient puts on the cuff incorrectly or does not have validated equipment. Many
studies indicated that both home and ambulatory blood pressure monitoring reduce health care
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costs associated with hypertension because fewer visits are needed and a reduction in
antihypertensive medications occurs. However, office blood pressure monitoring still remains the
single method in diagnosing and managing hypertension, partly due to the longstanding tradition
of office blood pressure measurement, even though it can be highly inconsistent and inaccurate.
In 2011, NICE made a recommendation that “if the clinic blood pressure is 140/90 mmHg or
higher, offer ambulatory blood pressure monitoring to confirm the diagnosis of hypertension”
(NICE, 2011, p.12). Essentially, all individuals that are diagnosed with hypertension should
undergo a secondary analysis using ABPM. Another study advised that patients under the age of
50, with low cardiovascular risk, that have office blood pressure readings in the high normal and
low hypertensive range be reevaluated by a supplemental blood pressure measurement method of
either ABPM or HBPM (Krakoff, Pickering, & Phillips, 2002).
One of the main barriers to both ambulatory and home blood pressure monitoring for
practices in Maine is the cost of the equipment. Patients may not be able to afford a home blood
pressure machine or their insurance may not cover the use of ABPM. Practices also find that the
cost of the equipment and the necessary staff training will be too high to receive any return on
investment. Contradictory to this perception, the literature reviewed in the previous section
suggests that ABPM is the most cost effective method of diagnosing and managing hypertension.
Another benefit of both home and ambulatory blood pressure monitoring is the ability to
predict cardiovascular events and identify target organ damage, whereas OBPM does not have
that capability. This fact alone makes ABPM and HBPM superior to OBPM and is a facilitator to
improving population health.
In the context of the Triple Aim, it is time that primary care practices should consider the
accuracy of 24-hour ambulatory and home blood pressure monitoring when diagnosing patients
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with hypertension. It is also important that these practices address the barriers as to why there is
limited use of the “gold standard” of blood pressure monitoring methods. Although the ABPM
cuff may be uncomfortable for patients and interfere with their normal routine, the fact that it can
improve health outcomes for hypertensive patients makes it a viable blood pressure method that
should be part of the diagnostic pathway for hypertension.
This author suggests that primary care practices develop and initiate pilot projects that utilize
either ABPM or HBPM as a supplemental diagnostic tool. Also recommended for improved
management of hypertension is the inclusion of home blood pressure monitoring as part of the
hypertensive patient care management plan. As primary care practices begin to implement
different methods of obtaining accurate blood pressure readings, and address the barriers and
facilitators to these methods within their practice, it is predicted these changes will result in a
reduction in overall costs to patients, an increase in population health, and improve the patient
experience.
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Appendix A
Recruitment letter for primary care practices to participate in key informant interviews:
Dear ____________________,

My name is Elizabeth Andrews and I am in my final semester of the Master of Public Health
Program at the University of Southern Maine’s Muskie School of Public Service. In order to
receive my degree, I must complete a final project called a capstone. I have chosen to do my
capstone on blood pressure monitoring of hypertensive patients in primary care. Focusing on the
barriers and facilitators to ambulatory, office, and home blood pressure monitoring in the context
of the Triple Aim; population health, the patient experience, and per capita cost. This is a very
interesting topic to me due to the increasing number of people diagnosed with hypertension, the
high costs surrounding the management of this disease, and the true accuracy of each method of
blood pressure measurement/monitoring.
In order to gain a more informed qualitative perspective on the benefits and drawbacks of each
blood pressure monitoring method, I wish to conduct a small interview with you to learn how
your practice uses the different blood pressure monitoring methods to diagnose and manage
hypertension.
The interview should not take more than 15 minutes of your time and if you decide to participate,
you can e-mail your responses to me, agree to a phone interview that fits best with your
schedule, or send your responses by mail (if you choose this method, I will mail a copy of the
questions along with a self-addressed, stamped envelope.)
I have attached the interview questions and consent form to this e-mail to give you an
opportunity to review the consent form and questions and decide whether you wish to participate
in this research project or not. Your name and the name of your organization will not be reported
in the research, nor will any possibly identifiable information be included in the final project.
Thank you for your time. I would greatly appreciate your involvement in my final project at
Muskie and hope to hear from you soon!

Sincerely,
Elizabeth Andrews
Phone: 207-329-8653
E-mail: elizabeth.r.andrews@maine.edu
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Appendix B
Interview questions for participating primary care practices:
Interview Questions
Blood pressure monitoring of hypertensive patients in primary care: barriers and facilitators to
ambulatory, office, and home blood pressure monitoring in the context of the Triple Aim
By: Elizabeth Andrews
1. Can you provide an estimate as to the percentage of your organization’s patient population
that has a diagnosis of hypertension?
2. Does your organization have any standard protocol in place for diagnosing hypertension
regarding blood pressure measurement? If yes, please describe.
3. Does your organization have a protocol for the continued management of hypertensive
patients? (i.e. antihypertensive medication, regular office blood pressure checks, homemonitoring) If yes, please describe.
4. Please rate the following blood pressure measurement methods on a scale of most commonly
to least commonly used in your practice for the diagnosis and management of hypertension:
a. Clinic blood pressure monitoring
b. Home blood pressure monitoring
c. 24-hour ambulatory blood pressure monitoring
5. Does your practice recommend home blood pressure monitoring to all of your hypertensive
patients? If so, do you find that the patients who participate in their care are more controlled
and involved in the management of their hypertension?
6. Does your practice ever prescribe 24-hour ambulatory blood pressure monitoring in order to
diagnose or monitor hypertensive patients? If so, why would a patient be asked to participate
in ambulatory blood pressure monitoring?
7. Please identify any barriers to clinic, home and ambulatory blood pressure monitoring
methods in terms of accessibility, cost, and the patient experience.
8. Can you list some benefits to each of the aforementioned methods in terms of accessibility,
cost, and the patient experience?
9. Can you explain why the selected blood pressure monitoring method from Question 4 is the
most commonly used in your practice for the diagnosis and management of hypertension?
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